Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1301

1.

Consumption of trans fats and estimated effects on coronary heart disease in Iran.

Mozaffarian D, Abdollahi M, Campos H, Houshiarrad A, Willett WC.

Eur J Clin Nutr. 2007 Aug;61(8):1004-10. Epub 2007 Jan 31.

PMID:
17268422
2.

Health effects of trans-fatty acids: experimental and observational evidence.

Mozaffarian D, Aro A, Willett WC.

Eur J Clin Nutr. 2009 May;63 Suppl 2:S5-21. doi: 10.1038/sj.ejcn.1602973. Review.

PMID:
19424218
3.
4.

Role of trans fatty acids in health and challenges to their reduction in Indian foods.

Ghafoorunissa G.

Asia Pac J Clin Nutr. 2008;17 Suppl 1:212-5. Review.

5.

Feasibility of recommending certain replacement or alternative fats.

Skeaff CM.

Eur J Clin Nutr. 2009 May;63 Suppl 2:S34-49. doi: 10.1038/sj.ejcn.1602974.

PMID:
19424217
6.

Trans fatty acids and cardiovascular health: translation of the evidence base.

Booker CS, Mann JI.

Nutr Metab Cardiovasc Dis. 2008 Jul;18(6):448-56. doi: 10.1016/j.numecd.2008.02.005. Epub 2008 May 12. Review.

PMID:
18468872
7.

Trans fats in America: a review of their use, consumption, health implications, and regulation.

Remig V, Franklin B, Margolis S, Kostas G, Nece T, Street JC.

J Am Diet Assoc. 2010 Apr;110(4):585-92. doi: 10.1016/j.jada.2009.12.024. Review.

PMID:
20338284
8.

Saturated and cis- and trans-unsaturated fatty acids intake in rural and urban Costa Rican adolescents.

Monge-Rojas R, Campos H, Fernández Rojas X.

J Am Coll Nutr. 2005 Aug;24(4):286-93.

PMID:
16093406
9.

Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans.

Chardigny JM, Malpuech-Brugère C, Dionisi F, Bauman DE, German B, Mensink RP, Combe N, Chaumont P, Barbano DM, Enjalbert F, Bezelgues JB, Cristiani I, Moulin J, Boirie Y, Golay PA, Giuffrida F, Sébédio JL, Destaillats F.

Contemp Clin Trials. 2006 Aug;27(4):364-73. Epub 2006 Apr 24.

PMID:
16632411
10.

Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.

Dyerberg J, Eskesen DC, Andersen PW, Astrup A, Buemann B, Christensen JH, Clausen P, Rasmussen BF, Schmidt EB, Tholstrup T, Toft E, Toubro S, Stender S.

Eur J Clin Nutr. 2004 Jul;58(7):1062-70.

PMID:
15220949
11.

[Trans-fatty acids--effects on coronary heart disease].

Karbowska J, Kochan Z.

Pol Merkur Lekarski. 2011 Jul;31(181):56-9. Review. Polish.

PMID:
21870712
12.

Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review.

Hunter JE, Zhang J, Kris-Etherton PM.

Am J Clin Nutr. 2010 Jan;91(1):46-63. doi: 10.3945/ajcn.2009.27661. Epub 2009 Nov 25. Review.

PMID:
19939984
13.

Nutritional properties of trans fatty acids.

Sambaiah K, Lokesh BR.

Indian J Biochem Biophys. 1999 Aug;36(4):211-20. Review.

PMID:
10650721
14.

[Dietary trans-fatty acids: a risk factor for coronary disease].

Zock PL, Urgert R, Hulshof PJ, Katan MB.

Ned Tijdschr Geneeskd. 1998 Jul 25;142(30):1701-4. Review. Dutch.

PMID:
9763864
15.

Adipose tissue trans fatty acids and risk of coronary artery disease: a case-control study.

Ghahremanpour F, Firoozrai M, Darabi M, Zavarei A, Mohebbi A.

Ann Nutr Metab. 2008;52(1):24-8. doi: 10.1159/000114291. Epub 2008 Jan 30.

PMID:
18230967
16.

Consumption and health effects of trans fatty acids: a review.

Teegala SM, Willett WC, Mozaffarian D.

J AOAC Int. 2009 Sep-Oct;92(5):1250-7. Review.

PMID:
19916363
17.

Trans fatty acids and cardiovascular risk.

Wilson TA, McIntyre M, Nicolosi RJ.

J Nutr Health Aging. 2001;5(3):184-7. Review.

PMID:
11458290
18.

[Trans fatty acids: effects on lipoprotein metabolism and cardiovascular risk].

Attia-Skhiri N, Fournier N, Pourci ML, Paul JL.

Ann Biol Clin (Paris). 2009 Sep-Oct;67(5):517-23. doi: 10.1684/abc.2009.0358. Review. French.

19.

Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population.

Ratnayake WM, L'Abbe MR, Farnworth S, Dumais L, Gagnon C, Lampi B, Casey V, Mohottalage D, Rondeau I, Underhill L, Vigneault M, Lillycrop W, Meleta M, Wong LY, Ng T, Gao Y, Kwong K, Chalouh S, Pantazopoulos P, Gunaratna H, Rahardja A, Blagden R, Roscoe V, Krakalovich T, Neumann G, Lombaert GA.

J AOAC Int. 2009 Sep-Oct;92(5):1258-76.

PMID:
19916364
20.

Supplemental Content

Support Center